Frontiers in Cellular and Infection Microbiology · 2023 · 17 citations · 39 references
Life SciencesInfectious DiseasesMicrobiologyDrug DiscoveryMolecular VirologyVirologyAnimal VirusesAntiviral AgentsMolecular DockingViral InfectionsViral PathogenesisVirus-host InteractionsAntiviral Drug DesignAntiviral Structure-activity RelationshipsAntiviral TherapeuticsIn-vitro CharacterizationMolecular Docking ValidationViral Protease FunctionViral Protease InhibitionViral Proteases
The high mortality rate of weaned piglets infected with porcine epidemic diarrhea virus (PEDV) poses a serious threat to the pig industry worldwide, demanding urgent research efforts related to developing effective antiviral drugs to prevent and treat PEDV infection. Small molecules can possibly prevent the spread of infection by targeting specific vital components of the pathogen’s genome. Main protease (Mpro, also named 3CL protease) plays essential roles in PEDV replication and has emerged as a promising target for the inhibition of PEDV. In this study, wogonin exhibited antiviral activity against a PEDV variant isolate, interacting with the PEDV particles and inhibiting the internalization, replication and release of PEDV. The molecular docking model indicated that wogonin was firmly embedded in the groove of the active pocket of Mpro. Furthermore, the interaction between wogonin and Mpro was validated in silico via microscale thermophoresis and surface plasmon resonance analyses. In addition, the results of a fluorescence resonance energy transfer (FRET) assay indicated that wogonin exerted an inhibitory effect on Mpro. These findings provide useful insights into the antiviral activities of wogonin, which could support future research into anti-PEDV drugs.`
39
Coronavirus Main Proteinase (3CL <sup>pro</sup> ) Structure: Basis for Design of Anti-SARS Drugs
K. Anand, John Ziebuhr, Parvesh Wadhwani et al. · Science · 2003 · 1.8K citations
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai, Bing Zhang, Xia-Ming Jiang et al. · Science · 2020 · 1.6K citations · Full text
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson et al. · Nature · 2022 · 469 citations · Full text
Antiviral Chinese medicinal herbs against respiratory syncytial virus
Shuang‐Cheng Ma, Jiang Du, Paul Pui‐Hay But et al. · Journal of Ethnopharmacology · 2002 · 276 citations
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
Min‐Feng Hsu, Chih‐Jung Kuo, Kai‐Ti Chang et al. · Journal of Biological Chemistry · 2005 · 264 citations · Full text